- Report
- December 2022
- 53 Pages
Global
From €3087EUR$3,500USD£2,662GBP
- Book
- June 2020
- 198 Pages
- Book
- September 2019
- 302 Pages
- Report
- November 2021
- 747 Pages
Global
From €3528EUR$4,000USD£3,043GBP
- Book
- August 2023
- 1360 Pages
- Book
- August 2023
- 224 Pages
- Book
- May 2023
- 512 Pages
- Book
- May 2023
- 512 Pages
- Book
- April 2023
- 2000 Pages
- Book
- March 2023
- 1056 Pages
- Book
- August 2022
- 320 Pages
- Book
- June 2022
- 560 Pages
- Book
- June 2022
- 496 Pages
- Book
- April 2020
- 320 Pages
- Book
- February 2020
- 202 Pages
- Book
- September 2019
- 688 Pages
- Book
- December 2018
- 784 Pages

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more